Risk assessment process and management procedure

This document details the procedure within IDEA-FAST by which the project risks are identified, categorised and monitored. The most important, critical risks are already described in Annex I of the Grant Agreement. Additional risks will be identified as part of the project review and planning process.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.